(thirdQuint)IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer.

 OBJECTIVES: - Determine the efficacy of IH636 grape seed proanthocyanidin extract for the treatment of radiation-induced fibrosis after high-dose radiotherapy in women with a history of early breast cancer.

 OUTLINE: This is a randomized, double-blind, placebo-controlled study.

 Patients are stratified according to time since prior radiotherapy.

 Patients are randomized to 1 of 2 arms.

 - Arm I: Patients receive oral IH636 grape seed proanthocyanidin extract three times daily for 6 months.

 - Arm II: Patients receive an oral placebo three times daily for 6 months.

 Patients are followed at 6 months.

 PROJECTED ACCRUAL: A total of 72 patients (48 for arm I and 24 for arm II) will be accrued for this study.

.

 IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer@highlight

RATIONALE: IH636 grape seed extract may lessen hardening of breast tissue caused by radiation therapy and may help patients live more comfortably.

 PURPOSE: Randomized phase II trial to study the effectiveness of IH636 grape seed extract in treating hardening of breast tissue in women who have undergone radiation therapy for early breast cancer.

